The global pregnancy medication market size accounted for US$ 39.68 billion in 2023 and is projected to reach around USD 135.43 billion by 2033, growing at a CAGR of 13.06% from 2024 to 2033.
Key Points
- North America dominated the market with the largest share in 2023.
- Asia Pacific is expected to witness the fastest rate of growth during the forecast period.
- By type, under the drug class segment, the antacids sub-segment accounted for the dominating share in the market in 2023.
- By type, under the drug class segment, the antianemia sub-segment is observed to witness a notable rate of growth during the forecast period.
- By distribution channel, the hospital pharmacy segment held the largest share of the market in 2023.
- By distribution channel, the online pharmacy segment is observed to experience a significant rate of growth during the forecast period.
- By pregnancy stage, the 3rd-trimester segment dominated the market in 2023.
Report Summary
The global pregnancy medication market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.
The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the pregnancy medication market across the globe.
A comprehensive estimate on the pregnancy medication market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of pregnancy medication during the forecast period. Price point comparison by region with global average price is also considered in the study.
Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3893
Pregnancy Medication Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 13.06% |
| Global Market Size in 2023 | USD 39.68 Billion |
| Global Market Size by 2033 | USD 135.43 Billion |
| Largest Market | North America |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Type, By Distribution Channel, and By Pregnancy Stage |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Key Highlights:
Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized pregnancy medication market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.
Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.
Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.
Also Read: Cloud-based Contact Center Market Size to Attain USD 155.74 Bn by 2033
Market Players
The report includes the profiles of key pregnancy medication market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.
Recent Developments
- In March 2023, Pfizer unveiled its plans to launch RSV vaccines for older adults and pregnant women in the US and Europe. Pfizer opened a new tab and is ready to launch its respiratory syncytial virus (RSV) vaccine. Both Pfizer and British drugmaker GSK opened a new tab that has RSV vaccines which they are planning to launch in the United States and Europe.
- In November 2023, Wayne State launched a preterm birth awareness campaign. Wayne State University’s Office of Women’s Health serves as the coordinating center of the SOS MATERNITY Network in Michigan.
- In March 2023, BJ Government Medical College in Pune collaborated with Johns Hopkins
- University and Weill Cornell Medical College, USA launched a new study to assess Tuberculosis (TB), Human Immunodeficiency Viruses (HIV), and gestational diabetes among pregnant women.
Pregnancy Medication Market Companies
- Roche Holding AG
- Pfizer
- Glenmark Pharmaceuticals Ltd
- Alkem Laboratories Limited
- Lupin Limited
- Amgen Inc
- AbbVie
- Piramal Enterprises Limited
- Sanofi
- Janssen
- Sun Pharma
- Regeneron
- Dr. Reddy’s Laboratories
- Alembic Pharmaceuticals Ltd
- Takeda
- Cipla Inc
- Viatris Inc(Mylan Inc.)
- GSK
Segments Covered in the Report
By Type
- Drug Class
- Antianemia
- Antacids
- Antiallergic
- Analgesics
- Antimicrobials
- Nutritional Supplements
- Others
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Pregnancy Stage
- 3rd-trimester
- 1st trimester
- 2nd trimester
Regional Segmentation
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Research Methodology
Secondary Research
It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
- In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Pregnancy Medication Market
5.1. COVID-19 Landscape: Pregnancy Medication Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Pregnancy Medication Market, By Type
8.1. Pregnancy Medication Market Revenue and Volume, by Type, 2024-2033
8.1.1 Drug Class
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Nutritional Supplements
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Others
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global Pregnancy Medication Market, By Distribution Channel
9.1. Pregnancy Medication Market Revenue and Volume, by Distribution Channel, 2024-2033
9.1.1. Hospital Pharmacy
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Retail Pharmacy
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1.3. Online Pharmacy
9.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. Global Pregnancy Medication Market, By Pregnancy Stage
10.1. Pregnancy Medication Market Revenue and Volume, by Pregnancy Stage, 2024-2033
10.1.1. 3rd-trimester
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. 1st trimester
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
10.1.3. 2nd trimester
10.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 11. Global Pregnancy Medication Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.1.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.1.3. Market Revenue and Volume Forecast, by Pregnancy Stage (2021-2033)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.1.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.1.4.3. Market Revenue and Volume Forecast, by Pregnancy Stage (2021-2033)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.1.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.1.5.3. Market Revenue and Volume Forecast, by Pregnancy Stage (2021-2033)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.2.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.2.3. Market Revenue and Volume Forecast, by Pregnancy Stage (2021-2033)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.2.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.2.4.3. Market Revenue and Volume Forecast, by Pregnancy Stage (2021-2033)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.2.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.2.5.3. Market Revenue and Volume Forecast, by Pregnancy Stage (2021-2033)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.2.6.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.2.6.3. Market Revenue and Volume Forecast, by Pregnancy Stage (2021-2033)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.2.7.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.2.7.3. Market Revenue and Volume Forecast, by Pregnancy Stage (2021-2033)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.3.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.3.3. Market Revenue and Volume Forecast, by Pregnancy Stage (2021-2033)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.3.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.3.4.3. Market Revenue and Volume Forecast, by Pregnancy Stage (2021-2033)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.3.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.3.5.3. Market Revenue and Volume Forecast, by Pregnancy Stage (2021-2033)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.3.6.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.3.6.3. Market Revenue and Volume Forecast, by Pregnancy Stage (2021-2033)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.3.7.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.3.7.3. Market Revenue and Volume Forecast, by Pregnancy Stage (2021-2033)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.4.3. Market Revenue and Volume Forecast, by Pregnancy Stage (2021-2033)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.4.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.4.4.3. Market Revenue and Volume Forecast, by Pregnancy Stage (2021-2033)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.4.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.4.5.3. Market Revenue and Volume Forecast, by Pregnancy Stage (2021-2033)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.4.6.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.4.6.3. Market Revenue and Volume Forecast, by Pregnancy Stage (2021-2033)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.4.7.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.4.7.3. Market Revenue and Volume Forecast, by Pregnancy Stage (2021-2033)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.5.3. Market Revenue and Volume Forecast, by Pregnancy Stage (2021-2033)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.5.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.5.4.3. Market Revenue and Volume Forecast, by Pregnancy Stage (2021-2033)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.5.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
11.5.5.3. Market Revenue and Volume Forecast, by Pregnancy Stage (2021-2033)
Chapter 12. Company Profiles
12.1. Roche Holding AG
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Pfizer
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Glenmark Pharmaceuticals Ltd
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Alkem Laboratories Limited
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Lupin Limited
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Amgen Inc
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. AbbVie
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Piramal Enterprises Limited
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Sanofi
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Janssen
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
